Business Wire

Mobile Ticket Option Now Available for New York CityPASS Program

Jaa

New York City’s original big-savings ticket booklet now offers a mobile ticket option. The New York CityPASS® program, which saves travelers 40% off admission to the Big Apple’s very best attractions, including the Empire State Building, The Metropolitan Museum of Art and American Museum of Natural History, has gone mobile.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171128005460/en/

New York CityPASS mobile ticket. (Photo: Business Wire)

New York CityPASS mobile ticket. (Photo: Business Wire)

Offering packaged, discounted admission to the most iconic attractions in 12 North American destinations, City Pass, Inc. has always focused on making travel easier and less expensive. The company’s decision to offer mobile tickets—a move that dramatically enhances convenience for travelers—began last month with the successful launch of a similar option for the Tampa Bay CityPASS program.

“It was exciting to watch the debut of the New York mobile ticket option unfold in real time,” said CityPASS President and CEO Megan Allen. “Shortly after the option went live on our website, a pair of mobile tickets was purchased in Euros by a traveler who selected French as their language. Five minutes later, those same tickets were scanned for entry at one of our partner attractions.”

The language option is a benefit that will be applied to all future mobile ticket programs for other CityPASS partner destinations. Mobile tickets will be delivered to the purchaser’s smartphone in the language the buyer used while browsing the CityPASS website. For international visitors, it is especially helpful to have an end-to-end translated experience in the language of their choosing.

The New York CityPASS program includes prepaid admission to:

  • The Empire State Building (CityPASS day/night ticket includes two general admission visits: one during the day and a return visit the same night)
  • American Museum of Natural History
  • The Metropolitan Museum of Art
  • Option: Top of the Rock Observation Deck OR Guggenheim Museum
  • Option: Statue of Liberty & Ellis Island OR Circle Line Sightseeing Cruise
  • Option: 9/11 Memorial & Museum OR Intrepid Sea, Air & Space Museum

The included tickets are valid over a period of nine consecutive days, beginning with the first day of use.

The mobile ticket will work in the same manner as printed CityPASS ticket booklets, although instead of scanning a printed ticket at the attraction, the visitor will scan their phone. Mobile tickets, as well as ticket booklets, can be purchased online at CityPASS.com. Current prices (valid through Feb. 28, 2018): $122 for adults; $98 for children (6-17).

For 20 years, CityPASS ticket booklets and admission cards have been premier products for travelers who want to visit a destination’s top attractions while enjoying significant savings. CityPASS booklets/admission cards, which have a 98 percent customer recommendation rating, are available for New York City, Atlanta, Boston, Chicago, Dallas, Houston, Philadelphia, San Francisco, Seattle, Southern California, Tampa Bay and Toronto. For more information, visit CityPASS.com.

Prices and programs subject to change. CityPASS ® is a registered trademark of City Pass, Inc., and the exclusive property of City Pass, Inc.

Contact information

CityPASS
Deborah Wakefield, APR, 503-292-4418
deborah@citypass.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

ISAE-SUPAERO Launches a New MOOC in the Field of Space and Aeronautics18.1.2019 11:00Tiedote

ISAE-SUPAERO, the world leader in aerospace engineering training has launched a new MOOC for the start of 2019: "DynaMOOC". “DynaMOOC”: understand and apply the fundamentals of structural dynamics The basic architecture of aerospace structures is generally founded on static criteria. The modern approach consists of integrating the dynamics not to certification but also to the fundamental design and specification of aerospace structures and light structures. Thus, all areas which involve structural works are affected: aircraft, vehicles, naval engineering and civil engineering. In-depth knowledge of the fundamentals of dynamics offers a new perspective on the classification and behavior of all mechanical systems. This MOOC goes back to the basics of solid dynamics applied to structural analysis. This four-week course is aimed at undergraduate students in mechanical or physical engineering who would like to comprehend the transition from statics to dynamics, as well as to structural engi

Ipsen: Patients Living with Spasticity Want Long-lasting Symptom Relief18.1.2019 09:30Tiedote

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190117005697/en/ Carenity Infographic Ipsen (Euronext: IPN; ADR: IPSEY) today presents at TOXINS, results from an international survey revealing the hidden burden of spasticity and the need for longer periods of symptomatic relief1. Affecting 12 million people around the world2, spasticity is one of the most common and disabling conditions associated with neurological diseases in adults (stroke, traumatic brain, etc.) and characterised by an abnormal increase in muscle tone or stiffness3. A survey of 615 respondents from 6 participating countries confirms that spasticity has a profound impact on ability to perform everyday tasks, including the ability to carry items, walk, and drive and reduces independence overall. The survey1 also found that spasticity affects the ability to work (22% of patients surveyed did not work) and impacts sex life as well as self-este

A Better Way to Earn Interest on Digital Assets18.1.2019 04:00Tiedote

Cred, the leading provider of crypto borrowing and lending with over $300 million in credit facilities, today announced the launch of CredEarn* on the Uphold platform. CredEarn allows Uphold customers to lend their crypto and fiat assets to Cred and receive up to 10% of annualized interest. “We’re thrilled to offer consumers the opportunity to earn interest on their digital assets and fiat currencies,” said Dan Schatt, Co-founder and President of Cred. “In a bear market, customers can benefit from the liquidity they receive when obtaining a fixed amount of interest in USD or Stablecoin. In a bull market, customers also benefit by receiving the full upside on the amount of crypto they originally committed.” CredEarn customers can commit to a six-month term with the ability to rollover assets for additional periods. No account minimum is needed and interest is paid out in U.S. Dollars or Stablecoin every three months on Uphold. The principal is paid back in the fiat or crypto amounts tha

Servier and Taiho Oncology Present Latest LONSURF® (trifluridine/tipiracil) Data at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)18.1.2019 02:45Tiedote

Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today that the safety and efficacy data in the gastrectomy patient subgroup of the global Phase III trial TAGS evaluating LONSURF® (trifluridine/tipiracil, TAS-102) in patients with metastatic gastric cancer (mGC) are consistent with the overall study results published in The Lancet Oncology. These data were highlighted in an oral presentation at the ASCO 2019 Gastrointestinal Cancers Symposium (ASCO-GI) on Thursday 17 January. In TAGS, 221 (44%) of the 507 randomized mGC patients had undergone prior gastrectomy (147 LONSURF, 74 placebo), which is reflective of the real-world patient population diagnosed with mGC. The results confirmed that trifluridine/tipiracil prolonged survival versus placebo regardless of prior gastrectomy. The overall results of TAGS demonstrated that patients treated with oral trifluridine/tipiracil showed a clinically meaningful and statistically s

ISACA Announces 2019 Slate of Events for Business Technology Professionals Around the Globe During its 50th Anniversary Year17.1.2019 22:24Tiedote

ISACA, a global association serving technology audit, assurance, governance and cybersecurity professionals, celebrating its 50th anniversary in 2019, announced its annual event schedule, which includes learning opportunities focused on emerging technologies, innovation, best practices and professional development. Disruptive technologies over the last 50 years and in the future of business enterprise, and the evolution of technology careers and ISACA professions, will be featured in conjunction with the ISACA anniversary year at nearly every venue. ISACA’s growing Cybersecurity Solution Portfolio, including the CSX Training Platform and the CMMI Cybermaturity Platform, will be highlighted in new conferences in 2019, which will include events in North America and Europe. The 2019 CACS conferences, set for North America, Europe, Asia, Africa, the Oceania region and Latin America, will offer educational sessions in audit and assurance, big data, risk management, governance and more. All

HighLife Closes a €32 Million Round B Financing17.1.2019 20:25Tiedote

HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which includes regulatory approval trials in Europe to obtain the CE mark and a first clinical trial in the U.S. via an Early Feasibility Study (EFS). The Series B round was co-led by U.S. Venture Partners (“USVP”) and Andera Partners, with Sectoral Asset Management and Jose Calle Gordo, Chairman of the company, joining the round. Sofinnova Partners, which led the Series A round, continues to support the company and participated in this latest round of financing. Bryan Garnier & Co (Paris) acted as private placement agent for this financing. “I am very pleased to announce the closing of the Ser

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme